On this page

Vaxneuvance

Pneumococcal 15-valent Conjugate Vaccine

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Vaxneuvance

Proper name

Pneumococcal 15-valent Conjugate Vaccine

Licence type

351(a)

BLA number

125741

Applicant

Merck Sharp & Dohme LLC

Center

CBER

Presentations

First licensure

July 16, 2021

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
2.0UG	Injection	Intramuscular	Pre-Filled Syringe	Rx	July 16, 2021

Purple Book	FDA	Licence type, presentations, reference product, exclusivity